1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer : A Multi-institutional Study
(
- Contribution to journal › Article
-
Mark
Artificial intelligence for detection of prostate cancer in biopsies during active surveillance
2024) In BJU International(
- Contribution to journal › Article
- 2021
-
Mark
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
(
- Contribution to journal › Article
- 2019
-
Mark
Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
(
- Contribution to journal › Article
- 2017
-
Mark
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Immediate versus delayed prostatectomy : Nationwide population-based study
(
- Contribution to journal › Article
- 2015
-
Mark
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
(
- Contribution to journal › Article
- 2013
-
Mark
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
(
- Contribution to journal › Article
- 2011
-
Mark
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
(
- Contribution to journal › Scientific review